Investigating the Neural Oscillatory Features for Limited Access to Oral Language in Deaf Children With Early Bilateral Cochlear Implantation
ICO
1 other identifier
observational
150
0 countries
N/A
Brief Summary
Children with severe-to-profound congenital hearing loss often experience significant language development challenges. While cochlear implants (CIs) can restore auditory input, outcomes vary widely, even among those who receive implants early (before age 2) and undergo consistent speech therapy. This study aims to identify neural mechanisms underlying these differences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
July 31, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
Study Completion
Last participant's last visit for all outcomes
September 1, 2028
July 31, 2026
July 1, 2026
1 year
July 28, 2026
July 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The beta coefficient of theta-gamma phase-amplitude coupling (PAC) in the linear mixed-effect model
language composite score is the dependent variable
at enrollment
Secondary Outcomes (4)
Power-spectrum density (PSD) of the EEG resting-state oscillations
at enrollment
peak frequencies of the EEG resting-state oscillations
at enrollment
Multivariate temporal response functions (mTRF) in audiovisual and audio conditions
at enrollment
Comparison of the 40Hz Auditory steady-state responses (ASSR) between participants with or without GJB2 variant
at enrollment
Eligibility Criteria
This study will involve minors (between 4 and 17 years-old) with congenital severe-to-profound hearing loss with early bilateral CIs from pediatric ENT department of Necker hospital in Paris.
You may qualify if:
- Age of first implantation less than or equal to 30 months
- Bilateral CIs
- Received CIs simultaneously or sequentially (the interval between two implantations does not exceed 18 months)
- Congenital severe-to-profound hearing loss (PTA ≥90 dB HL)
You may not qualify if:
- Children with severe associated disabilities who are assessed as unable to complete the tasks
- Patients who, in the medical opinion of the Investigator, are unlikely to comply with the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Pasteurlead
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2026
First Posted
July 31, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2028
Last Updated
July 31, 2026
Record last verified: 2026-07